About
Tepary bean (Phaseolus acutifolius Gray) is a drought-tolerant legume native to the US–Mexico border region, valued for its high protein content (13–32% by variety) and richness in carbohydrates, lipids, amino acids, minerals, phenols, and antioxidants. It is consumed as a whole food and is increasingly studied as a functional ingredient and protein concentrate for use in food formulations.
Safety summary
Tepary beans are generally safe for consumption when properly cooked; studies suggest their incorporation in the diet does not introduce adverse toxic effects compared to common beans and may support protection against metabolic diseases such as diabetes, heart disease, and certain cancers. Like all legumes, raw tepary beans contain antinutritional factors—including lectins, tannins, trypsin inhibitors, saponins, and phytic acid—that can reduce digestibility and cause adverse effects if consumed raw or undercooked; proper cooking substantially mitigates these risks. Concentrated lectin fractions at high experimental doses have shown reversible intestinal damage in animal studies, but this is not a concern for normally cooked whole beans consumed at typical dietary intakes.
Regulatory landscape
| Jurisdiction | Status | Note |
|---|---|---|
| COFEPRIS / SENASICA (Mexico) | Approved | Tepary bean is a traditional food crop of northern Mexico (notably Sonora and Chihuahua states) with centuries of documented consumption. No specific regulatory restriction or maximum intake has been identified; it is sold freely in local markets.source |
| FDA (Food and Drug Administration) (United States) | Approved | Tepary bean is a whole food/legume with a long history of traditional consumption in the US Southwest and Mexico. As a whole food ingredient, it is not subject to FDA food additive pre-market approval; no specific GRAS notice or food additive regulation has been identified for tepary bean in the FDA Substances Added to Food inventory. It falls under general FDA food safety oversight (FSMA, 21 CFR).source |
Who should approach with care
Research citations
- 1PubMed. Assessment of Genotoxicity and Cytotoxicity of Tepary Bean (Phaseolus acutifolius) Seed Protein Extract, 2025. pmc.ncbi.nlm.nih.gov
- 2PubMed. Protein Concentrates on Tepary Bean (Phaseolus acutifolius Gray) as a Functional Ingredient: In silico Docking of Tepary Bean Lectin to Peroxisome Proliferator-Activated Receptor Gamma, 2021. pmc.ncbi.nlm.nih.gov
- 3PubMed. Tepary bean (Phaseolus acutifolius) lectin fraction provokes reversible adverse effects on rats' digestive tract, 2020. pmc.ncbi.nlm.nih.gov
- 4PubMed. Effects of intragastrically-administered Tepary bean lectins on digestive and immune organs: Preclinical evaluation, 2017. ncbi.nlm.nih.gov
- 5PubMed. Tannins, trypsin inhibitors and lectin cytotoxicity in tepary (Phaseolus acutifolius) and common (Phaseolus vulgaris) beans, 2005. pubmed.ncbi.nlm.nih.gov
